Cross state-dependency of learning between WIN55, 212-2 and scopolamine in rat dorsal hippocampus

Neuroscience Letters

Volumn 491, Issue 3, 2011, Pages 227-231

  Jamali Raeufy, Nida ^a,b   Nasehi, Mohammad ^c   Ebrahimi ghiri, Mohaddeseh ^a   Zarrindast, Mohammad Reza ^a,b,d,e,f  

^a INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

Author keywords

212 2; Hippocampus; Rats; Scopolamine; Step through; WIN55

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; SCOPOLAMINE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; STATE DEPENDENT LEARNING;

ANIMALS; BENZOXAZINES; CALCIUM CHANNEL BLOCKERS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; LEARNING; MALE; MEMORY; MORPHOLINES; MUSCARINIC ANTAGONISTS; NAPHTHALENES; RATS; RATS, WISTAR; SCOPOLAMINE;

EID: 79951771909     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.01.056     Document Type: Article

References (26)

1. Azami N.S., Piri M., Oryan S., Jahanshahi M., Babapour V., Zarrindast M.R. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol. Learn. Mem. 2010, 93:455-462.
2. Braida D., Sala M. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats. Neuroreport 2000, 11:2025-2029.
3. Clarke J.R., Rossato J.I., Monteiro S., Bevilaqua L.R., Izquierdo I., Cammarota M. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory. Neurobiol. Learn. Mem. 2008, 90:374-381.
4. De Oliveira Alvares L., Genro B.P., Diehl F., Quillfeldt J.A. Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol. Learn. Mem. 2008, 90:1-9.
5. Ghorbanalizadeh-Khalifeh-Mahaleh B., Taheri S., Sahebgharani M., Rezayof A., Haeri-Rohani A., Zarrindast M.R. Intra-dorsal hippocampal microinjections of lithium and scopolamine induce a cross state-dependent learning in mice. Arch. Iran. Med. 2008, 11:629-638.
6. Kim Y.H., Lee Y., Kim D., Jung M.W., Lee C.J. Scopolamine-induced learning impairment reversed by physostigmine in zebrafish. Neurosci. Res. 2010, 67:156-161.
7. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci. Biobehav. Rev. 2010.
8. Mackie K. Signaling via CNS cannabinoid receptors. Mol. Cell. Endocrinol. 2008, 286:S60-65.
9. Mishima K., Egashira N., Matsumoto Y., Iwasaki K., Fujiwara M. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Life Sci. 2002, 72:397-407.
10. Nasehi M., Piri M., Jamali-Raeufy N., Zarrindast M.R. Influence of intracerebral administration of NO agents in dorsal hippocampus (CA1) on cannabinoid state-dependent memory in the step-down passive avoidance test. Physiol. Behav. 2010, 100:297-304.
11. Nasehi M., Sahebgharani M., Haeri-Rohani A., Zarrindast M.R. Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol. Learn. Mem. 2009, 92:391-399.
12. Ohno-Shosaku T., Tsubokawa H., Mizushima I., Yoneda N., Zimmer A., Kano M. Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. J. Neurosci. 2002, 22:3864-3872.
13. Orgado J.M., Fernandez-Ruiz J., Romero J. The endocannabinoid system in neuropathological states. Int. Rev. Psychiatry 2009, 21:172-180.
14. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Academic Press, London, UK. 6th ed.
15. Quirarte G.L., Cruz-Morales S.E., Cepeda A., Garcia-Montanez M., Roldan-Roldan G., Prado-Alcala R.A. Effects of central muscarinic blockade on passive avoidance: anterograde amnesia, state dependency, or both?. Behav. Neural Biol. 1994, 62:15-20.
16. Quistad G.B, Nomura D.K., Sparks S.E., Segall Y., Casida J.E. Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticides,. Toxicol. Lett. 2002, 135:89-93.
17. Rezayof A., Khajehpour L., Zarrindast M.R. The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors. Neuroscience 2009, 160:255-263.
18. Rezayof A., Zare-Chahoki A., Zarrindast M.R., Rassouli Y. Inhibition of dorsal hippocampal nitric oxide synthesis potentiates ethanol-induced state-dependent memory in mice. Behav. Brain Res. 2010, 209:189-195.
19. Robinson L., Goonawardena A.V., Pertwee R., Hampson R.E., Platt B., Riedel G. WIN55 212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav. Brain Res. 2010, 208:584-592.
20. Ryberg E., Larsson N., Sjogren S., Hjorth S., Hermansson N.O., Leonova J., Elebring T., Nilsson K., Drmota T., Greasley P.J. The orphan receptor GPR55 is a novel cannabinoid receptor. Br. J. Pharmacol. 2007, 152:1092-1101.
21. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 2001, 22:565-572.
22. Szabo B., Schlicker E. Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol. 2005, 327-365.
23. Terranova J.P., Storme J.J., Lafon N., Perio A., Rinaldi-Carmona M., Le Fur G., Soubrie P. Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist SR 141716. Psychopharmacology (Berl.) 1996, 126:165-172.
24. Tzavara E.T., Wade M., Nomikos G.G. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J. Neurosci. 2003, 23:9374-9384.
25. Zarrindast M.R., Dorrani M., Lachinani R., Rezayof A. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice. Neurosci. Res. 2010, 67:25-32.
26. Zarrindast M.R., Nasehi M., Piri M., Bina P. Anxiety-like behavior induced by histaminergic agents can be prevented by cannabinoidergic WIN55, 212-2 injected into the dorsal hippocampus in mice. Pharmacol. Biochem. Behav. 2010, 94:387-396.